Effects of Rituximab in a large series of patients with HCV-associated mixed cryoglobulinemia syndrome

CLINICAL TRIALS AND OBSERVATIONS CME article

Patrice Cacoub

October 2016

cryoglobulinemia (MC) may target either the viral trigger (HCV) or the downstream B-cell clonal expa...

CLINICAL TRIALS AND OBSERVATIONS

September 2016

Pegylated interferon-, ribavirin, and rituximab combined therapy of hepatitis C virus–related mixed ...

A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis

De Vita S
Quartuccio L
Isola M
Mazzaro C
Scaini P
Lenzi M
Campanini M
Naclerio C
Tavoni A
Pietrogrande M
Masolini P
Zabotti A
Maset M
Roccatello D
Zignego AL
Pioltelli P
Gabrielli A
Filippini D
Perrella O
Migliaresi S
Galli M
Bombardieri S
Monti G.
FERRI, Clodoveo
MASCIA, Maria Teresa

January 2012

OBJECTIVE: To conduct a long-term, prospective, randomized controlled trial evaluating rituximab (RT...

Effects of Rituximab in a large series of patients with HCV-associated mixed cryoglobulinemia syndrome

FERRI, Clodoveo
SEBASTIANI, Marco
P. Cacoub
D. Roccatello
P. Scaini
A. Tavoni
A. L. Zignego
S. De Vita

January 2010

A multicenter retrospective study about efficacy and safety of rituximab in mixed cryoglobulinemia s...

Treatment with rituximab in patients with mixed cryoglobulinemia syndrome: results of multicenter cohort study and review of the literature.

FERRI, Clodoveo
SEBASTIANI, Marco
P. Cacoub
C. Mazzaro
D. Roccatello
P. Scaini
A. Tavoni
A. L. Zignego
S. De Vita

January 2011

OBJECTIVE:Mixed cryoglobulinemia syndrome (MCs) is a systemic vasculitis characterized by multiple o...

Efficacy and safety of rituximab in type II mixed cryoglobulinemia

November 2019

10The best treatment of type II mixed cryoglobulinemia (MC) has still to be defined. Antiviral treat...

Management of mixed cryoglobulinemia with rituximab: evidence and consensus-based recommendations from the Italian Study Group of Cryoglobulinemia (GISC)

Quartuccio, Luca
Bortoluzzi, Alessandra
Scirè, Carlo Alberto
Marangoni, Antonio
Del Frate, Giulia
Treppo, Elena
Castelnovo, Laura
Saccardo, Francesco
Zani, Roberta
Candela, Marco
Fraticelli, Paolo
Mazzaro, Cesare
Renoldi, Piero
Scaini, Patrizia
Filippini, Davide Antonio
Visentini, Marcella
Scarpato, Salvatore
Giuggioli, Dilia
Mascia, Maria Teresa
Sebastiani, Marco
Zignego, Anna Linda
Lauletta, Gianfranco
Fiorilli, Massimo
Casato, Milvia
Ferri, Clodoveo
Pietrogrande, Maurizio
Pioltelli, Pietro Enrico
De Vita, Salvatore
Monti, Giuseppe
Galli, Massimo

January 2022

Cryoglobulinemic vasculitis (CV) or mixed cryoglobulinemic syndrome (MCS) is a systemic small-vessel...

A phase II, single-arm multicenter study of low-dose rituximab for refractory mixed cryoglobulinemia secondary to hepatitis C virus infection

Marcella Visentini
Serena Ludovisi
Antonio Petrarca
Federica Pulvirenti
Marco Zaramella
Monica Monti
Valentina Conti
Jessica Ranieri
Stefania Colantuono
Elisa Fognani
Alessia Piluso
Carmine Tinelli
Anna Linda Zignego
Mario U. Mondelli
Massimo Fiorilli
Milvia Casato

January 2011

Eradication of hepatitis C virus (HCV) by antiviral therapy is the treatment of choice for mixed cry...

Combined Treatment with Antiviral Therapy and Rituximab in Patients with Mixed Cryoglobulinemia: Review of the Literature and Report of a Case Using Direct Antiviral Agents-Based Antihepatitis C Virus Therapy

Teresa Urraro
Laura Gragnani
Alessia Piluso
Alessio Fabbrizzi
Monica Monti
Elisa Fognani
Barbara Boldrini
Jessica Ranieri
Anna Linda Zignego

January 2015

Mixed cryoglobulinemia (MC) is an autoimmune/B-cell lymphoproliferative disorder associated with Hep...

Efficacy of low-dose rituximab for mixed cryoglobulinemia

Visentini, Marcella
Granata, Massimo
Veneziano, Maria Luisa
Borghese, Federica
Carlesimo, Maurizio
Fulvia, Pimpinelli
Fiorilli, Massimo
Casato, Milvia

January 2007

Rituximab at 375 mg/m(2) x 4 is effective for refractory HCV-related mixed cryoglobulinemia. We cond...

Case Report Combined Treatment with Antiviral Therapy and Rituximab in Patients with Mixed Cryoglobulinemia: Review of the Literature and Report of a Case Using Direct Antiviral

Agents-based Antihepatitis
C Virus Therapy
Teresa Urraro
Laura Gragnani
Alessia Piluso
Alessio Fabbrizzi
Monica Monti
Elisa Fognani
Barbara Boldrini
Jessica Ranieri
Anna Linda Zignego

August 2016

B-cell depletion in the treatment of mixed cryoglobulinemia.

SANSONNO, Domenico Ettore
GATTI, Pietro
LAULETTA, GIANFRANCO
Tucci FA
Montrone M
Troiani L
Sansonno L

January 2007

A controlled study has been carried out to assess the efficacy of rituximab (RTX), a chimeric antibo...

The role of Rituximab in the therapy of mixed cryoglobulinemia

Zaja F
Volpetti S
De Luca, S
Fanin, R

January 2012

The chimeric monoclonal antibody (IgG1/\u3ba) rituximab (RTX) is directed against the CD20 antigen, ...

MONOCLONAL ANTIBODY TREATMENT OF MIXED CRYOGLOBULINEMIA RESISTANT TO INTERFERON ALPHA WITH AN ANTI-CD20

SANSONNO, Domenico Ettore
LAULETTA, GIANFRANCO
DE RE V
TUCCI FA
BOIOCCHI M
DAMMACCO F.

January 2003

A controlled study has been carried out to assess the efficacy of rituximab, a chimeric antibody tha...

A randomized controlled trial of rituximab for treatment of severe cryoglobulinemic vasculitis.

De Vita, S.
Quartuccio, L.
Isola, M
Mazzaro, C.
Scaini, P.
Lenzi, M.
Campanini, M.
Naclerio, C.
Tavoni, A.
Pietrogrande, M.
Ferri, C.
Mascia, M. T
Masolini, P.
Zabotti, A.
Maset, M.
Roccatello, D.
Zignego, A. L.
Pioltelli, P.
Gabrielli, A.
Filippini, D.
Perrella, O.
Migliaresi, S.
Galli, M.
Bombardieri, S.
Monti, G.

January 2012

Objective To conduct a long-term, prospective, randomized controlled trial evaluating rituximab (RTX...

CLINICAL TRIALS AND OBSERVATIONS CME article

Patrice Cacoub

October 2016

cryoglobulinemia (MC) may target either the viral trigger (HCV) or the downstream B-cell clonal expa...

CLINICAL TRIALS AND OBSERVATIONS

September 2016

Pegylated interferon-, ribavirin, and rituximab combined therapy of hepatitis C virus–related mixed ...

A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis

De Vita S
Quartuccio L
Isola M
Mazzaro C
Scaini P
Lenzi M
Campanini M
Naclerio C
Tavoni A
Pietrogrande M
Masolini P
Zabotti A
Maset M
Roccatello D
Zignego AL
Pioltelli P
Gabrielli A
Filippini D
Perrella O
Migliaresi S
Galli M
Bombardieri S
Monti G.
FERRI, Clodoveo
MASCIA, Maria Teresa

January 2012

OBJECTIVE: To conduct a long-term, prospective, randomized controlled trial evaluating rituximab (RT...

Effects of Rituximab in a large series of patients with HCV-associated mixed cryoglobulinemia syndrome

FERRI, Clodoveo
SEBASTIANI, Marco
P. Cacoub
D. Roccatello
P. Scaini
A. Tavoni
A. L. Zignego
S. De Vita

January 2010

A multicenter retrospective study about efficacy and safety of rituximab in mixed cryoglobulinemia s...

Treatment with rituximab in patients with mixed cryoglobulinemia syndrome: results of multicenter cohort study and review of the literature.

FERRI, Clodoveo
SEBASTIANI, Marco
P. Cacoub
C. Mazzaro
D. Roccatello
P. Scaini
A. Tavoni
A. L. Zignego
S. De Vita

January 2011

OBJECTIVE:Mixed cryoglobulinemia syndrome (MCs) is a systemic vasculitis characterized by multiple o...

Efficacy and safety of rituximab in type II mixed cryoglobulinemia

November 2019

10The best treatment of type II mixed cryoglobulinemia (MC) has still to be defined. Antiviral treat...

Management of mixed cryoglobulinemia with rituximab: evidence and consensus-based recommendations from the Italian Study Group of Cryoglobulinemia (GISC)

Quartuccio, Luca
Bortoluzzi, Alessandra
Scirè, Carlo Alberto
Marangoni, Antonio
Del Frate, Giulia
Treppo, Elena
Castelnovo, Laura
Saccardo, Francesco
Zani, Roberta
Candela, Marco
Fraticelli, Paolo
Mazzaro, Cesare
Renoldi, Piero
Scaini, Patrizia
Filippini, Davide Antonio
Visentini, Marcella
Scarpato, Salvatore
Giuggioli, Dilia
Mascia, Maria Teresa
Sebastiani, Marco
Zignego, Anna Linda
Lauletta, Gianfranco
Fiorilli, Massimo
Casato, Milvia
Ferri, Clodoveo
Pietrogrande, Maurizio
Pioltelli, Pietro Enrico
De Vita, Salvatore
Monti, Giuseppe
Galli, Massimo

January 2022

Cryoglobulinemic vasculitis (CV) or mixed cryoglobulinemic syndrome (MCS) is a systemic small-vessel...

A phase II, single-arm multicenter study of low-dose rituximab for refractory mixed cryoglobulinemia secondary to hepatitis C virus infection

Marcella Visentini
Serena Ludovisi
Antonio Petrarca
Federica Pulvirenti
Marco Zaramella
Monica Monti
Valentina Conti
Jessica Ranieri
Stefania Colantuono
Elisa Fognani
Alessia Piluso
Carmine Tinelli
Anna Linda Zignego
Mario U. Mondelli
Massimo Fiorilli
Milvia Casato

January 2011

Eradication of hepatitis C virus (HCV) by antiviral therapy is the treatment of choice for mixed cry...

Combined Treatment with Antiviral Therapy and Rituximab in Patients with Mixed Cryoglobulinemia: Review of the Literature and Report of a Case Using Direct Antiviral Agents-Based Antihepatitis C Virus Therapy

Teresa Urraro
Laura Gragnani
Alessia Piluso
Alessio Fabbrizzi
Monica Monti
Elisa Fognani
Barbara Boldrini
Jessica Ranieri
Anna Linda Zignego

January 2015

Mixed cryoglobulinemia (MC) is an autoimmune/B-cell lymphoproliferative disorder associated with Hep...

Efficacy of low-dose rituximab for mixed cryoglobulinemia

Visentini, Marcella
Granata, Massimo
Veneziano, Maria Luisa
Borghese, Federica
Carlesimo, Maurizio
Fulvia, Pimpinelli
Fiorilli, Massimo
Casato, Milvia

January 2007

Rituximab at 375 mg/m(2) x 4 is effective for refractory HCV-related mixed cryoglobulinemia. We cond...

Case Report Combined Treatment with Antiviral Therapy and Rituximab in Patients with Mixed Cryoglobulinemia: Review of the Literature and Report of a Case Using Direct Antiviral

Agents-based Antihepatitis
C Virus Therapy
Teresa Urraro
Laura Gragnani
Alessia Piluso
Alessio Fabbrizzi
Monica Monti
Elisa Fognani
Barbara Boldrini
Jessica Ranieri
Anna Linda Zignego

August 2016

B-cell depletion in the treatment of mixed cryoglobulinemia.

SANSONNO, Domenico Ettore
GATTI, Pietro
LAULETTA, GIANFRANCO
Tucci FA
Montrone M
Troiani L
Sansonno L

January 2007

A controlled study has been carried out to assess the efficacy of rituximab (RTX), a chimeric antibo...

The role of Rituximab in the therapy of mixed cryoglobulinemia

Zaja F
Volpetti S
De Luca, S
Fanin, R

January 2012

The chimeric monoclonal antibody (IgG1/\u3ba) rituximab (RTX) is directed against the CD20 antigen, ...

MONOCLONAL ANTIBODY TREATMENT OF MIXED CRYOGLOBULINEMIA RESISTANT TO INTERFERON ALPHA WITH AN ANTI-CD20

SANSONNO, Domenico Ettore
LAULETTA, GIANFRANCO
DE RE V
TUCCI FA
BOIOCCHI M
DAMMACCO F.

January 2003

A controlled study has been carried out to assess the efficacy of rituximab, a chimeric antibody tha...

A randomized controlled trial of rituximab for treatment of severe cryoglobulinemic vasculitis.

De Vita, S.
Quartuccio, L.
Isola, M
Mazzaro, C.
Scaini, P.
Lenzi, M.
Campanini, M.
Naclerio, C.
Tavoni, A.
Pietrogrande, M.
Ferri, C.
Mascia, M. T
Masolini, P.
Zabotti, A.
Maset, M.
Roccatello, D.
Zignego, A. L.
Pioltelli, P.
Gabrielli, A.
Filippini, D.
Perrella, O.
Migliaresi, S.
Galli, M.
Bombardieri, S.
Monti, G.

January 2012

Objective To conduct a long-term, prospective, randomized controlled trial evaluating rituximab (RTX...

CLINICAL TRIALS AND OBSERVATIONS CME article

Patrice Cacoub

October 2016

cryoglobulinemia (MC) may target either the viral trigger (HCV) or the downstream B-cell clonal expa...

CLINICAL TRIALS AND OBSERVATIONS

September 2016

Pegylated interferon-, ribavirin, and rituximab combined therapy of hepatitis C virus–related mixed ...

A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis

De Vita S
Quartuccio L
Isola M
Mazzaro C
Scaini P
Lenzi M
Campanini M
Naclerio C
Tavoni A
Pietrogrande M
Masolini P
Zabotti A
Maset M
Roccatello D
Zignego AL
Pioltelli P
Gabrielli A
Filippini D
Perrella O
Migliaresi S
Galli M
Bombardieri S
Monti G.
FERRI, Clodoveo
MASCIA, Maria Teresa

January 2012

OBJECTIVE: To conduct a long-term, prospective, randomized controlled trial evaluating rituximab (RT...

Effects of Rituximab in a large series of patients with HCV-associated mixed cryoglobulinemia syndrome

Abstract

Extracted data

Effects of Rituximab in a large series of patients with HCV-associated mixed cryoglobulinemia syndrome

Abstract

Extracted data

Related items

Related items